focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,106.00
Bid: 1,107.50
Ask: 1,108.50
Change: 21.50 (1.98%)
Spread: 1.00 (0.09%)
Open: 1,080.00
High: 1,109.00
Low: 1,076.00
Prev. Close: 1,084.50
SGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sage issues GBP 400 million bond

1 Feb 2022 16:15

RNS Number : 3730A
Sage Group PLC
01 February 2022
 

Sage issues GBP 400 million bond

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (the UNITED STATES) OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT

 

1st February 2022

 

The Sage Group plc ("Sage") announces that it has launched and successfully priced a bond offering of GBP 400 million 2.875% notes due in February 2034 (the "Notes"). The offering is expected to settle on 8th February 2022 subject to the satisfaction of customary conditions.

 

The Notes issue extends the maturity of the Group's debt portfolio. Sage intends to use the proceeds to repay certain existing indebtedness and for general corporate purposes. Sage has been rated BBB+ (stable) by S&P.

 

Application will be made for the Notes to be admitted to the official list of the Financial Conduct Authority and to be admitted to trading on the regulated market of the London Stock Exchange.

 

The Joint Bookrunners were BofA Securities, HSBC, J.P. Morgan and NatWest Markets

 

 

Enquiries

 

The Sage Group plc +44 (0) 7900 046714

 

James Sandford, VP Investor Relations

Amy Lawson, EVP Communications

Jacqui Cartin, EVP Group Financial Controller / James Thomas, VP Treasury

 

 

Finsbury Glover Hering +44 (0) 20 7251 3801

Conor McClaffertyAmanda Healy

 

 

About Sage

 

Sage exists to knock down barriers so everyone can thrive, starting with the millions of Small and Mid-Sized Businesses served by us, our partners and accountants. Customers trust our finance, HR and payroll software to make work and money flow. By digitising business processes and relationships with customers, suppliers, employees, banks and governments, our digital network connects SMBs, removing friction and delivering insights. Knocking down barriers also means we use our time, technology and experience to tackle digital inequality, economic inequality and the climate crisis.

 

 

DISCLAIMER

 

This announcement does not constitute an offering of the Notes for sale in the United States. This is not for distribution in the United States. The Notes have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act") and are subject to U.S. tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the Notes in the United States.

 

Under no circumstances shall this announcement constitute an offer to sell or the solicitation of an offer to buy any Notes in any jurisdiction where it is unlawful to do so. Recipients of this announcement who intend to subscribe for or purchase the Notes are reminded that any subscription or purchase may only be made on the basis of the information contained in the final prospectus relating to the Notes.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLGDDSBGDGDB
Date   Source Headline
7th Dec 20236:00 pmRNSDirector/PDMR Shareholding
7th Dec 202311:00 amRNSNotice of AGM
7th Dec 20237:00 amRNSUpdate on financial reporting
6th Dec 20236:11 pmRNSTransaction in Own Shares
6th Dec 20235:30 pmRNSDirector/PDMR Shareholding
6th Dec 20232:00 pmRNSBlock listing Interim Review
5th Dec 20236:20 pmRNSTransaction in Own Shares
5th Dec 202311:00 amRNSAnnual Financial Report
4th Dec 20236:28 pmRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20236:09 pmRNSTotal Voting Rights
30th Nov 20236:03 pmRNSTransaction in Own Shares
29th Nov 20236:15 pmRNSTransaction in Own Shares
28th Nov 20236:18 pmRNSTransaction in Own Shares
27th Nov 20235:36 pmRNSTransaction in Own Shares
24th Nov 20236:24 pmRNSTransaction in Own Shares
22nd Nov 20232:30 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSResults for the year ended 30 September 2023
22nd Nov 20237:00 amRNSSHARE BUYBACK PROGRAMME
31st Oct 20234:45 pmRNSTotal Voting Rights
27th Sep 202310:39 amRNSDirectorate Change
21st Sep 202310:00 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInvestor and Analyst Event
11th Sep 20233:34 pmRNSHolding(s) in Company
31st Aug 20234:45 pmRNSTotal Voting Rights
31st Aug 20232:00 pmRNSDirector/PDMR Shareholding
16th Aug 20232:56 pmRNSDirector/PDMR Shareholding
10th Aug 20234:38 pmRNSDirector/PDMR Shareholding
1st Aug 20232:54 pmRNSDirector/PDMR Shareholding
31st Jul 20234:30 pmRNSTotal Voting Rights
27th Jul 20237:00 amRNSTrading update for nine months ended 30 June 2023
30th Jun 20232:40 pmRNSTotal Voting Rights
30th Jun 20239:48 amRNSDirector/PDMR Shareholding
27th Jun 20235:16 pmRNSDirector/PDMR Shareholding
21st Jun 20239:00 amRNSDirector/PDMR Shareholding
6th Jun 202312:02 pmRNSBlock listing Interim Review
31st May 20234:55 pmRNSHolding(s) in Company
31st May 20234:50 pmRNSTotal Voting Rights
30th May 202310:10 amRNSDirector/PDMR Shareholding
19th May 20234:58 pmRNSDirector/PDMR Shareholding
19th May 20234:45 pmRNSHolding(s) in Company
17th May 20237:00 amRNSResults for the six months to 31 March 2023
28th Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20232:11 pmRNSDirector/PDMR Shareholding
31st Mar 202312:40 pmRNSTotal Voting Rights
27th Mar 20231:40 pmRNSDirector/PDMR Shareholding
6th Mar 20234:42 pmRNSHolding(s) in Company
28th Feb 20231:50 pmRNSTotal Voting Rights
17th Feb 20235:22 pmRNSDirector/PDMR Shareholding
17th Feb 20235:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.